Skip to content

ALZAMEND NEURO, INC.: 10-Q filed 2023-03-15

What ALZAMEND NEURO, INC. reported in its quarterly report filed 2023-03-15 (fiscal Q3 2023): 27 published measures, 73 facts as tagged in accession 0001214659-23-003850.

This filing

Form
10-Q (quarterly report)
Filed
2023-03-15
Fiscal period
fiscal Q3 2023
Accession
0001214659-23-003850 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ALZAMEND NEURO, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-01-318,501,978USD
At 2022-04-3014,516,443USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-01-312,642,473USD
At 2022-04-301,164,932USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-01-315,859,505USD
At 2022-10-318,787,423USD
At 2022-04-3013,351,511USD
At 2022-01-3111,962,139USD
At 2021-10-3113,025,411USD
At 2021-04-302,012,945USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-01-317,375,841USD
At 2022-04-3014,063,811USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-11-01 to 2023-01-31-5,425,574USD92
2022-05-01 to 2023-01-31-11,572,639USD276
2021-11-01 to 2022-01-31-2,572,865USD92
2021-05-01 to 2022-01-31-8,492,661USD276

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-05-01 to 2023-01-31-6,687,970USD276
2021-05-01 to 2022-01-31-5,051,637USD276

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-05-01 to 2022-01-3114,912,656USD276

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-01-31-40,767,134USD
At 2022-04-30-29,194,495USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-11-01 to 2023-01-3198,326,175shares92
2022-05-01 to 2023-01-3197,765,471shares276
2021-11-01 to 2022-01-3194,165,225shares92
2021-05-01 to 2022-01-3189,484,601shares276

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-11-01 to 2023-01-31-0.06USD/shares92
2022-05-01 to 2023-01-31-0.12USD/shares276
2021-11-01 to 2022-01-31-0.03USD/shares92
2021-05-01 to 2022-01-31-0.09USD/shares276

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-01-3185,166USD
At 2022-04-30102,909USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-05-01 to 2023-01-313,091,299USD276
2021-05-01 to 2022-01-313,150,801USD276

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-11-01 to 2023-01-31-5,423,512USD92
2022-05-01 to 2023-01-31-11,565,457USD276
2021-11-01 to 2022-01-31-2,556,566USD92
2021-05-01 to 2022-01-31-8,446,739USD276

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-01-318,416,812USD
At 2022-04-3014,413,534USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2022-11-01 to 2023-01-312,062USD92
2022-05-01 to 2023-01-317,182USD276
2021-11-01 to 2022-01-3116,299USD92
2021-05-01 to 2022-01-3145,922USD276

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-01-312,642,473USD
At 2022-04-301,164,932USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-01-312,642,473USD
At 2022-04-301,162,850USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-11-01 to 2023-01-312,888,847USD92
2022-05-01 to 2023-01-315,797,789USD276
2021-11-01 to 2022-01-31873,653USD92
2021-05-01 to 2022-01-313,540,111USD276

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-01-3196,427,624shares
At 2022-04-3095,481,790shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-01-317,375,841USD
At 2022-04-3014,063,811USD
At 2022-01-3111,790,289USD
At 2021-04-301,929,270USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-01-3161,500,292USD
At 2022-04-3057,419,753USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-01-31546,303USD
At 2022-04-30349,723USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2022-11-01 to 2023-01-315,400,000USD92
2022-05-01 to 2023-01-3111,600,000USD276

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-11-01 to 2023-01-312,534,665USD92
2022-05-01 to 2023-01-315,767,668USD276
2021-11-01 to 2022-01-311,682,913USD92
2021-05-01 to 2022-01-314,906,628USD276

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2022-05-01 to 2023-01-3117,743USD276

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-11-01 to 2023-01-31-2,062USD92
2022-05-01 to 2023-01-31-7,182USD276
2021-11-01 to 2022-01-31-16,299USD92
2021-05-01 to 2022-01-31-45,922USD276

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2021-05-01 to 2022-01-312,000,000USD276

Inspect the source

Entity
ALZAMEND NEURO, INC. / CIK 0001677077
Captured
2026-09-19T11:20:15.101Z
SEC response SHA-256
e091f00311cdd2d05377e177e0a2cf10b9fbab20ba26d0f97f3815f0b0cf6790

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001677077.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))